WESPAC Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

WESPAC Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,679	Closed	-$1.56M	–	117
2016 Q3	$1.56M	Buy	15,679 +4,081	+35%	+$400K	1.77%	15
2016 Q2	$1.04M	Buy	11,598 +1,214	+12%	+$112K	1.07%	39
2016 Q1	$909K	Buy	+10,384	New	+$915K	1.13%	38
2015 Q2	–	Sell	-30,126	Closed	-$3.56M	–	122
2015 Q1	$3.56M	Sell	30,126 -425	-1%	-$48K	2.7%	2
2014 Q4	$3.12M	Buy	+30,551	New	+$2.98M	2.19%	7
2014 Q2	–	Sell	-24,559	Closed	-$1.88M	–	117
2014 Q1	$1.88M	Buy	+24,559	New	+$1.92M	1.63%	16
2013 Q4	–	Sell	-6,320	Closed	-$410K	–	146
2013 Q3	$410K	Buy	+6,320	New	+$400K	0.48%	77

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

WESPAC Advisors's FBT Position: Q4 2016 in Review

WESPAC Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2016, closing a stake of 15,679 shares — an estimated $1.56M sold.

WESPAC Advisors first reported a position in FBT in Q3 2013 and held it in 7 quarters. The position peaked at $3.56M in Q1 2015. 110 funds tracked by Wall St. Rank hold FBT as of Q4 2016.

WESPAC Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2016 after selling out during the quarter.
WESPAC Advisors sold 15,679 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2016, an estimated $1.56M.
WESPAC Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2013 and held it in 7 quarters.
WESPAC Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.56M in Q1 2015.
110 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2016.

Based on WESPAC Advisors's 13F filing for Q4 2016, filed 1 Feb 2017.